Can perimenopause cause acne on the buttocks and genital area in a woman in her mid‑40s with no recent sexual activity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Perimenopause Cause Buttock and Genital Acne?

Yes, perimenopause can cause acne on the buttocks and genital area due to hormonal fluctuations, specifically the relative increase in androgens as estrogen levels decline during this transition period.

Understanding the Hormonal Mechanism

During perimenopause, women experience significant hormonal shifts. As estrogen levels begin to decline while androgen levels remain relatively stable or decrease more slowly, this creates a relative hyperandrogenic state 1. This hormonal imbalance can manifest as clinical hyperandrogenism, presenting as acne, hirsutism, and androgenetic alopecia 1.

The pathophysiology mirrors what occurs during puberty but in reverse—during puberty there's relative hyperandrogenism with insufficient estrogen modulation, while in perimenopause the declining estrogen creates a similar imbalance 2. Androgens stimulate the pilosebaceous unit (the hair follicle and sebaceous gland complex), leading to increased sebum production and acne development 3.

Key Clinical Features

Acne in perimenopausal women typically presents as:

  • Persistent or new-onset acne in the mid-40s
  • Lesions on the lower face (jawline/chin), but can also affect the trunk, buttocks, and genital areas
  • Often associated with premenstrual flares
  • May be accompanied by other signs of hyperandrogenism (excess hair growth on face, abdomen, inner thighs, or buttocks) 3

When to Investigate Further

Most perimenopausal women with isolated acne lesions have normal androgen levels and don't require extensive hormonal workup 1. However, baseline investigations are warranted if you observe:

  • Virilization signs: clitoromegaly, deepening voice, significant hirsutism
  • Severe or treatment-resistant acne
  • Associated symptoms: oligomenorrhea, infertility, truncal obesity
  • Sudden onset of severe acne (consider androgen-secreting tumor)
  • Other metabolic concerns: obesity, diabetes, hypertension, dyslipidemia 1

If investigation is needed, consider testing total testosterone, free testosterone, DHEA-S, and 17-hydroxyprogesterone to exclude polycystic ovarian syndrome, late-onset congenital adrenal hyperplasia, or tumors 4, 1.

Treatment Approach

First-Line: Topical Therapy

For mild to moderate acne without virilization, prolonged topical therapy is the mainstay 1:

  • Topical retinoids (adapalene, tretinoin, tazarotene, trifarotene) - strongly recommended 4
  • Benzoyl peroxide - strongly recommended, can be combined with retinoids 4
  • Topical antibiotics (clindamycin) - should be combined with benzoyl peroxide to prevent resistance 4
  • Azelaic acid or salicylic acid - conditionally recommended 4

Important caveat: Mature perimenopausal skin is more sensitive to irritation. Topical retinoids and benzoyl peroxide may cause excessive dryness or irritation, so consider starting with lower concentrations or using azelaic acid as an alternative 5.

Systemic Therapy Options

For moderate to severe acne or inadequate response to topicals:

  1. Spironolactone (first-choice oral anti-androgen):

    • Effective for hormonal acne in perimenopausal women 1, 6
    • Typical dosing: 50-200 mg daily
    • Potassium monitoring is unnecessary unless specific risk factors exist (renal disease, medications affecting potassium, older age with comorbidities) 4, 6
    • Can be continued long-term
  2. Oral antibiotics (doxycycline, minocycline, sarecycline):

    • Strongly recommended for doxycycline; conditionally for others 4
    • Should be limited in duration and combined with topical benzoyl peroxide 4
    • Not a long-term solution
  3. Combined oral contraceptives:

    • Effective for acne treatment 7
    • However, relatively contraindicated in postmenopausal women due to increased cardiovascular and thromboembolic risks 1
    • May be considered in early perimenopause if no contraindications exist and contraception is desired
    • Takes 3+ months to see improvement 7
  4. Oral isotretinoin:

    • Strongly recommended for severe acne, treatment-resistant acne, or acne causing scarring/psychosocial burden 4
    • Low-dose isotretinoin may be particularly helpful in this age group 1, 5
    • Requires pregnancy prevention in women of childbearing potential 4

Procedural Options

Consider adjunctive treatments that address both acne and age-related skin changes:

  • Intralesional corticosteroids for larger papules/nodules at risk of scarring 4
  • Chemical peels, laser treatments, or other procedures can help with acne scars and concomitant skin aging 1

Important Differential Considerations

Not all "acne" in the genital/buttock area is acne vulgaris. Consider:

  • Folliculitis (bacterial, fungal, or mechanical)
  • Hidradenitis suppurativa (chronic inflammatory condition of apocrine glands)
  • Contact dermatitis from products or clothing
  • Pityrosporum folliculitis (yeast-related, presents as monomorphic truncal papules/pustules) 4
  • Gram-negative folliculitis (if uniform pustules/nodules, especially with prolonged antibiotic use) 4

If lesions are uniform, monomorphic, or treatment-resistant, consider microbiologic testing 4.

Lifestyle Modifications

Address contributing factors that may worsen acne 1:

  • Stress reduction
  • Weight management (obesity worsens insulin resistance and hyperandrogenism)
  • Healthy diet (limit high-glycemic foods)
  • Regular exercise
  • Proper skincare routine avoiding comedogenic products
  • Adequate sleep

The Bottom Line

Perimenopause absolutely can cause acne on the buttocks and genital area through hormonal mechanisms. The relative androgen excess during this transition affects pilosebaceous units throughout the body, not just the face. Most cases respond well to topical therapy, with spironolactone being the preferred systemic option when needed. The absence of recent sexual activity makes sexually transmitted infections unlikely, but doesn't exclude other follicular conditions that should be considered if the presentation is atypical or treatment-resistant.

References

Research

Menopausal Acne - Challenges And Solutions.

International journal of women's health, 2019

Research

[Feminine acne: dermatologic disease or endocrine disease?].

Gynecologie, obstetrique & fertilite, 2002

Guideline

american association of clinical endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2001

Guideline

guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology, 2024

Research

Acne and its management beyond the age of 35 years.

American journal of clinical dermatology, 2004

Guideline

guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.